Baby’s Only Organic® LactoRelief™ with DHA and Baby’s Only Organic® Dairy with DHA Formula meets the nutrient composition recommendations of the American Academy of Pediatrics and the nutrient requirements of the U.S. Infant Formula Act. The requirements of the Infant Formula Act are based on years of clinical research on the appropriate nutrient composition for a breast milk substitute. All ingredients used in Baby’s Only Organic® LactoRelief™ with DHA Baby’s Only Organic® Dairy with DHA Formula are well known and have been safely used in pediatric nutrition for decades. Baby’s Only Organic® formulas do not contain any novel foods, functional food ingredients, “designer oils”, or GMO ingredients.
The use of egg phospholipids in infant formula has been widely studied. (1 - 12) A few highlights of these studies have shown the following:
- In a study with premature infants, DHA from egg phospholipid was better absorbed than DHA from single cell organism triglyceride oil. (6)
- DHA from egg phospholipid increased red blood cell levels in infants and improved visual acuity. (10)
- Infants fed a formula with egg phospholipid had a lower incidence of necrotizing enterocolitis (infection of the intestine). (5)
(1) Agostoni C, Trojan S, Bellu R, et al. “Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids,” Pediatric Research. 1995; 38:262-266.
(2) Agostoni C, Trojan S, Bellu R, et al. “Developmental quotient at 24 months and fatty acid composition of diet in early infancy: a follow-up study,” Archives of Diseases in Childhood. 1997; 76:421-424.
(3) Amate L, Gil A, Ramirez M. “Feeding infant piglets formula with long-chain polyunsaturated fatty acids as triacylglycerols or phospholipids influences the distribution of these fatty acids in plasma lipoprotein fractions,” Journal of Nutrition. 2001; 131:1250-1255.
(4) Bouwstra H, Dijck-Brouwer DAJ, Wildeman JAL, et al. “Long-chain polyunsaturated fatty acids have a positive effect on the quality of general movements of healthy term infants,” American Journal of Clinical Nutrition. 2003; 78:313-318.
(5) Carlson SE, Montalto MB, Ponder DL, et al. “Lower incidence of necrotizing enterocolitis in infants fed a preterm formula with egg phospholipids,” Pediatric Research. 1998; 44:491-498.
(6) Carnielli VP, Luijendijk IHT, Van Goudoever JB, et al. “Feeding premature newborn infants palmitic acid in amount and stereoisomeric position similar to that of human milk: effects on fat and mineral balance,” American Journal of Clinical Nutrition. 1995; 61:1037-1042.
(7) Forsyth JS, Willatts P, Agostoni C, et al. “Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow-up of a randomized controlled trial,” British Medical Journal. 2003; 326:953-955.
(8) Lopez-Pedrosa JM, Ramirez M, Torres MI, Gil A. “Dietary phospholipids rich in long-chain polyunsaturated fatty acid improve the repair of small intestine in malnourished piglets,” Journal of Nutrition. 1999; 129:1149-1155.
(9) Morgan C, Davies L, Corcoran F, et al. “Fatty acid balance studies in term infants fed formula milk containing long-chain polyunsaturated fatty acids,” Acta Paediatrica. 1998; 87:136-142.
(10) Watson, RR, editor. Fatty Acids in Health Promotion and Disease Causation. Urbana, Illinois: AOCS Press, 2009: 804.
(11) Wijendran V, Huang MC, Diau GY, et al. “Efficacy of dietary arachidonic acid provided as triglyceride of phospholipid as substrate for brain arachidonic acid accretion in baboon neonates,” Pediatric Research. 2002; 51:263-264.
(12) Willatts P, Dijck-Brouwer DAJ, Wildeman JAL, et al. “Long-chain polyunsaturated fatty acids have a positive effect on the quality of general movements of healthy term infants,” American Journal of Clinical Nutrition. 2003; 78:313-318.